PATENT CLAIM ANALYSIS

Application Number: 16133260
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "389000"]

Abstract:
A composition for opththalmic administration comprising a formaldehyde releasing agent, sodium bicarbonate, and an ophthalmically suitable carrier or excipient is provided.

Claim (Index 36):
The composition of  claim 35  wherein the formaldehyde releasing agent is 1-(phenylmethoxy)-methanol, N-hydroxymethyl-N-(1,3-di(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-N\u2032-hydroxy-methylurea, 1,3-dimethylol-5,5-dimethyl-hydantoin, N,N\u2032-methylenebis-[N-[3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]]-urea, sodium hydroxymethyl glycinate, or 5-methyl-1-aza-3,7-dioxabicyclo[3.3.0]octane.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.04348
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15125558', '13623690', '12517382', '14240328', '15570016']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7435644626859808
- 35 USC 102 Novelty (BERT): 0.6798303878695532
- Combined Prediction Score: 0.737191055204338
- Mean Citation Score: 371.7965
- Max Citation Score: 709.6841400000003
- Similarity Product: 639.5495359654929

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test